The Scientist

» regulation

Most Recent

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: Stem Cell Lines Not Fit for Clinic

Stem Cell Lines Not Fit for Clinic

By | February 6, 2014

Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.  

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: GeneLink Settles

GeneLink Settles

By | January 14, 2014

Another personal genomics company faces government pressure—this time from the Federal Trade Commission.

0 Comments

image: 23andMe Steps Back

23andMe Steps Back

By | December 6, 2013

The company announces that it will stop offering health interpretations of personal genetic data.

4 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2013

Tracks and Shadows, The Gap, The Cure in the Code, and An Appetite for Wonder

0 Comments

image: EU Considers Curbing Antibiotic Use

EU Considers Curbing Antibiotic Use

By | July 30, 2013

The European Medicines Agency has recommended that farmers stop using the antibiotic colistin prophylactically, citing human health concerns.

0 Comments

image: Opinion: Racing Toward Invention

Opinion: Racing Toward Invention

By | July 23, 2013

A newly instated patent law discriminates against academics and small biotechs.

6 Comments

image: Medical Marijuana for Kids?

Medical Marijuana for Kids?

By | July 17, 2013

The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.

6 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Gut Feeling
    Daily News Gut Feeling

    Sensory cells of the mouse intestine let the brain know if certain compounds are present by speaking directly to gut neurons via serotonin.

  4. Immune Cells Deliver Cancer Drugs to the Brain
AAAS